Ramucirumab and Atezolizumab After Progression on Any Immune Checkpoint Blocker in NSCLC

Name: Ramucirumab and Atezolizumab After Progression on Any Immune Checkpoint Blocker in NSCLC
License: Public Domain

Washington University School of Medicine

ClinicalTrials.gov · Datasets · License: Public Domain

non-small cell lung cancer, non small cell lung cancer, nsclc

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 417561
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.